VAERS reports by lot

Seqirus / CSL Flu lot 195215: VAERS reports

26 VAERS reports list lot 195215 as a Seqirus / CSL Flu vaccine, received between 2017-09-07 and 2019-01-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
12%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3740%
Cardiac / Cardiovascular1112%
Musculoskeletal1112%
General / Systemic (non-local)1011%
Dermatological (non-injection-site)910%
Respiratory66%
Neurological44%
Thrombotic / Hematological22%
Allergic / Anaphylactic22%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York3
California2
Georgia2
South Carolina1
Ohio1
Nebraska1
New Mexico1
Wyoming1
North Carolina1
Wisconsin1
Florida1
New Jersey1

Reports by month received

2017-093
2017-106
2017-111
2017-123
2018-012
2019-0111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.